GCC Medical Device Registration: What You Need to Know?
Expanding into the Gulf Cooperation Council (GCC) region offers a strategic growth opportunity for medical device manufacturers, fueled by rapid advancements in healthcare infrastructure, increasing rates of chronic illnesses, and significant government investments in healthcare modernization.
However, navigating the regulatory landscape can be complex, as each GCC member state – Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, and Oman – maintains its own regulatory system. This overview highlights the essential requirements and considerations for successful medical device registration across the GCC region.
General Medical Device Registration Process in GCC countries
“Though requirements vary by country, the general steps for medical device registration in the GCC include:
1. Appointment of Local Authorized Representative (AR)
Manufacturers outside the GCC must appoint a local Authorized Representative (AR) or an in-country agent to represent & manage regulatory submissions, liaise with authorities and ensure compliance with post-market requirements. The AR is responsible for holding technical documentation and acting as the point of contact for regulators.
2. Classification of Device
Devices are classified based on risk, similar to EU MDR and FDA guidelines:
Device classification directly influences the level of documentation needed and the timelines applicable for regulatory approval.
3. Preparation of Technical Documentation
Regulatory authorities mandate a complete technical dossier and Quality Management System compliant to ISO 13485, typically comprising:
· Device Description: Intended use, indications, and GMDN classification.
· Risk Assessment: Must be based on ISO 14971, showing risk controls and mitigation.
· Clinical Evaluation: Required especially for Class IIa and above either based on existing literature, clinical trials, or EU/US data.
· Performance and Safety Testing: Conformity to ISO, IEC, or ASTM standards for electrical, biocompatibility, usability, etc.
· Labeling & IFU: Must include Arabic and English though Arabic may be required at the outer packaging level or IFU depending on the country.
4. Submission of Registration Application
Each GCC country has its own regulatory submission system and specific requirements:
· Saudi Arabia (SFDA): Medical device applications are submitted through the GHAD system, and a Medical Device Marketing Authorization (MDMA) is mandatory for market access.
· United Arab Emirates (MOHAP & Dubai Municipality): Device registration is handled via MOHAP’s online portal, while Dubai Municipality may be involved for certain product types, such as cosmetics or disinfectants.
· Qatar (MOPH), Kuwait (KDFC), Bahrain (NHRA) and Oman (MOH): Submissions are made directly to each country’s Ministry of Health or Regulatory Authority and typically require prior approvals from recognized reference markets (such as the SFDA, EU CE Mark, or US FDA) to streamline the registration process.
5. Regulatory Review & Approval
Regulatory authorities review applications based on the medical device’s classification and associated risk level. The evaluation process may involve:
· Requests for supplementary information or clarifications
· On-site audits or facility inspections (typically for higher-risk devices)
· Local product testing or verification, where applicable
Estimated Regulatory Approval Timelines:
· Saudi Arabia (SFDA): Approximately 6–12 months
· United Arab Emirates (MOHAP & Dubai Municipality): Around 3–6 months
· Other GCC Countries (Qatar, Kuwait, Bahrain, Oman): Typically, 6–9 months, depending on device complexity and regulatory pathway.
6. Post-Market Surveillance & Compliance
Following approval, manufacturers are expected to fulfill ongoing post-market surveillance (PMS) responsibilities, including:
· Adverse Event Reporting: Timely notification of any device malfunctions or safety-related incidents.
· Vigilance and Recalls: Implementation of Corrective and Preventive Actions (CAPA) to address risks and ensure continued safety.
· Registration Renewals: Regulatory re-evaluation is required periodically, typically every 3–5 years depending on the specific country requirements.
Download the full GCC Medical Device Regulatory Comparison Matrix to get a detailed overview of requirements, timelines and country-specific processes across Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, and Oman – all in one handy reference table.
Conclusion
Registering medical devices in the GCC market demands meticulous planning, strategic local partnerships and strict adherence to each country’s unique regulatory framework. Manufacturers must navigate diverse requirements and understand the complexities to avoid costly delays with focus on timely approvals & sustained market access.
Whether you are launching a new device or expanding your footprint in the GCC, having experienced regulatory experts by your side can make all the difference. RegTrac offers comprehensive support throughout the entire registration lifecycle, from initial gap assessments and dossier preparation to regulatory submissions, local representation and ongoing compliance management.
Reach out to our dedicated GCC regulatory specialists today to develop a tailored regulatory strategy that accelerates your product’s entry and success in the Gulf region. Let us help you navigate the regulatory landscape with confidence and achieve your business goals efficiently. Book a free consultation today!
Informative Blogs
Our Services
Cosmetics
Medical Devices
Ready to take the next step? Let’s connect and explore how RegTrac can elevate your compliance journey!